X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82) 82
index medicus (72) 72
cystic fibrosis (63) 63
female (60) 60
respiratory system (59) 59
male (57) 57
child (46) 46
adolescent (43) 43
inflammation (29) 29
pediatrics (29) 29
children (28) 28
mutation (27) 27
young adult (27) 27
adult (25) 25
abridged index medicus (21) 21
critical care medicine (20) 20
cystic fibrosis - physiopathology (20) 20
child, preschool (18) 18
disease (17) 17
biomarkers (16) 16
cystic fibrosis - complications (15) 15
cystic fibrosis - microbiology (15) 15
diagnosis (15) 15
cystic fibrosis - drug therapy (14) 14
prospective studies (14) 14
sputum (14) 14
sputum - microbiology (14) 14
cystic fibrosis - genetics (13) 13
disease progression (13) 13
infant (13) 13
lung - physiopathology (13) 13
lung diseases (13) 13
middle aged (13) 13
respiratory function tests (13) 13
respiratory tract diseases (13) 13
cystic fibrosis - diagnosis (12) 12
infection (12) 12
kartagener syndrome - genetics (12) 12
pulmonary-function (12) 12
retrospective studies (12) 12
defects (11) 11
original research (11) 11
primary ciliary dyskinesia (11) 11
pulmonary exacerbation (11) 11
bacteria (10) 10
cohort studies (10) 10
health aspects (10) 10
infant, newborn (10) 10
lung-disease (10) 10
otorhinolaryngologic diseases (10) 10
care and treatment (9) 9
cystic fibrosis - metabolism (9) 9
cystic fibrosis transmembrane conductance regulator - genetics (9) 9
infants (9) 9
lung-function (9) 9
pseudomonas aeruginosa (9) 9
young-children (9) 9
analysis (8) 8
bronchoalveolar lavage (8) 8
forced expiratory volume (8) 8
infections (8) 8
kartagener syndrome - diagnosis (8) 8
movement disorders (8) 8
physiological aspects (8) 8
pseudomonas-aeruginosa (8) 8
pulmonary/respiratory (8) 8
risk factors (8) 8
treatment outcome (8) 8
airway inflammation (7) 7
anti-bacterial agents - therapeutic use (7) 7
antibiotics (7) 7
biomarkers - metabolism (7) 7
cystic fibrosis - immunology (7) 7
cystic fibrosis - therapy (7) 7
cystic-fibrosis (7) 7
genetic aspects (7) 7
research (7) 7
respiratory tract (7) 7
biomarkers - blood (6) 6
bronchoalveolar lavage fluid (6) 6
cilia (6) 6
cilia - ultrastructure (6) 6
clinical trials (6) 6
cytokines (6) 6
dynein regulatory complex (6) 6
fibrosis (6) 6
follow-up studies (6) 6
gene mutations (6) 6
genes (6) 6
genetics (6) 6
genetics & heredity (6) 6
genotype (6) 6
immunology (6) 6
kartagener syndrome (6) 6
lung - microbiology (6) 6
motility (6) 6
neutrophils (6) 6
phenotype (6) 6
proteins (6) 6
research article (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of respiratory and critical care medicine, ISSN 1535-4970, 2014, Volume 190, Issue 2, pp. 175 - 184
Rationale: Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator recently approved for patients with CF age 6 and older with... 
Cystic fibrosis | Pseudomonas aeruginosa | Ivacaftor | CFTR modulator | LUNG-FUNCTION | ivacaftor | MUCIN SECRETION | ADRENERGIC SWEAT SECRETION | MUCOCILIARY CLEARANCE | INTESTINAL PH | CHILDREN | RESPIRATORY SYSTEM | cystic fibrosis | PSEUDOMONAS-AERUGINOSA | INFLAMMATION | DISEASE | QUESTIONNAIRE | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Pseudomonas aeruginosa - isolation & purification | Follow-Up Studies | Forced Expiratory Volume - drug effects | Sweat - drug effects | Humans | Microbiota - drug effects | Respiratory System Agents - therapeutic use | Hospitalization - statistics & numerical data | Male | Aminophenols - therapeutic use | Quinolones - pharmacology | Aminophenols - pharmacology | Mucociliary Clearance - drug effects | Pseudomonas Infections - prevention & control | Young Adult | Hydrogen-Ion Concentration - drug effects | Quinolones - therapeutic use | Adult | Female | Lung - metabolism | Child | Biomarkers - metabolism | Respiratory System Agents - pharmacology | Cystic Fibrosis - metabolism | Cystic Fibrosis - microbiology | Pseudomonas Infections - complications | Pseudomonas Infections - diagnosis | Treatment Outcome | Lung - physiopathology | Genetic Markers | Sputum - metabolism | Cystic Fibrosis - genetics | Intestine, Small - drug effects | Lung - drug effects | Adolescent | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Intestine, Small - metabolism | Mutation | Cystic Fibrosis - drug therapy | Sweat - metabolism | Original
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 21, pp. 1991 - 2003
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2014, Volume 189, Issue 6, pp. 707 - 717
Journal Article
American journal of human genetics, ISSN 0002-9297, 2013, Volume 93, Issue 4, pp. 672 - 686
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 4, p. e62917
... of Colorado, Boulder, Colorado, United States of America Scott D. Sagel Affiliation: Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado... 
INFECTIONS | ANTIBIOTICS | SPUTUM | MULTIDISCIPLINARY SCIENCES | BACTERIAL COMMUNITIES | DESMOSINE | BARCODED PRIMERS | SAMPLES | FEV1 DECLINE | IDENTIFICATION | CHILDREN | Sputum - microbiology | Cystic Fibrosis - physiopathology | Humans | Bacteria - drug effects | Male | Respiratory System - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Inflammation - complications | Inflammation - drug therapy | Bacteria - classification | Adult | Female | Child | Inflammation - microbiology | Cross-Sectional Studies | Cystic Fibrosis - microbiology | Cystic Fibrosis - complications | Bacteria - genetics | Adolescent | Respiratory System - physiopathology | Anti-Bacterial Agents - pharmacology | Respiratory Function Tests | Metagenome | Cystic Fibrosis - drug therapy | Infection | C-reactive protein | Microbiota (Symbiotic organisms) | RNA | Analysis | Cystic fibrosis | Pulmonary function tests | Inflammation | Health aspects | Pediatrics | Respiratory function | rRNA 16S | Variability | Pseudomonas | Respiratory tract | Microbiota | Anaerobes | Bacteria | Elastase | Interleukin 8 | Deoxyribonucleic acid--DNA | Sequences | Lung diseases | Hospitalization | Morbidity | Medicine | Antibiotics | Fibrosis | Sputum | Relative abundance | Biomarkers | Anaerobic treatment | Deoxyribonucleic acid | DNA
Journal Article
Pediatric pulmonology, ISSN 8755-6863, 2016, Volume 51, Issue 2, pp. 115 - 132
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2018, Volume 197, Issue 12, pp. e24 - e39
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 10/2013, Volume 93, Issue 4, pp. 711 - 720
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 08/2013, Volume 93, Issue 2, pp. 336 - 345
Journal Article